Short Interest in Carmell Co. (NASDAQ:CTCX) Decreases By 33.3%

Carmell Co. (NASDAQ:CTCXGet Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 105,000 shares, a decrease of 33.3% from the November 30th total of 157,500 shares. Based on an average daily trading volume, of 5,770,000 shares, the short-interest ratio is currently 0.0 days. Currently, 0.8% of the shares of the company are sold short.

Institutional Trading of Carmell

An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC purchased a new stake in Carmell Co. (NASDAQ:CTCXFree Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned about 0.22% of Carmell as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 24.22% of the company’s stock.

Carmell Trading Down 5.1 %

Shares of NASDAQ:CTCX opened at $0.31 on Monday. Carmell has a twelve month low of $0.20 and a twelve month high of $4.00. The company’s 50 day moving average is $0.29 and its 200 day moving average is $0.71.

Carmell Company Profile

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Recommended Stories

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.